SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.410
-0.050 (-1.45%)
Sep 15, 2026, 4:00 PM EDT - Market closed
SAB Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -12.78 | 13.27 | -34.11 | -42.19 | -18.74 | -17.14 |
Depreciation & Amortization | 3.12 | 3.08 | 4.79 | 3.75 | 3.29 | 1.65 |
Other Amortization | 0.26 | 0.26 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | - | - | 0.04 | -0.02 | -0.01 |
Loss (Gain) From Sale of Investments | -0.07 | -0.07 | - | - | - | - |
Stock-Based Compensation | 16.68 | 5.21 | 2.94 | 2.42 | 2.67 | 2.31 |
Other Operating Activities | -56.63 | -62.84 | -5.62 | 8.53 | -10.43 | 3.49 |
Change in Accounts Receivable | - | - | - | 5.56 | 2.45 | 12.56 |
Change in Accounts Payable | 1.45 | 1.48 | 0.92 | -2.7 | -0.78 | -2.94 |
Change in Unearned Revenue | - | - | -1.32 | 1.32 | -0.1 | - |
Change in Other Net Operating Assets | -5.96 | -5.17 | -1.9 | -1.85 | -1.81 | 2.06 |
Operating Cash Flow | -53.94 | -44.78 | -34.29 | -25.12 | -23.46 | 1.99 |
Operating Cash Flow Growth | - | - | - | - | - | -80.14% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -3.5 | -0.93 | -0.34 | -0.2 | -2.17 | -10.94 |
Sale of Property, Plant & Equipment | 0 | 0 | - | 0.04 | 0.08 | - |
Investment in Securities | -198.61 | -120.77 | -11.63 | - | - | - |
Investing Cash Flow | -202.11 | -121.71 | -11.96 | -0.15 | -2.09 | -10.94 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 0.52 | 0.77 | 1.24 | 2.84 |
Long-Term Debt Repaid | - | -0.42 | -1.42 | -1.16 | -2.42 | -1.3 |
Total Debt Repaid | -0.15 | -0.42 | -1.42 | -1.16 | -2.42 | -1.3 |
Net Debt Issued (Repaid) | -0.15 | -0.42 | -0.91 | -0.39 | -1.19 | 1.54 |
Issuance of Common Stock | 261.1 | 168.73 | 0.02 | 59.66 | 7.76 | 0.01 |
Repurchase of Common Stock | -0.02 | -0.01 | -0.02 | - | - | - |
Other Financing Activities | -0 | -0 | -0.26 | - | -5.52 | 34.34 |
Financing Cash Flow | 260.93 | 168.3 | -1.17 | 66.77 | 1.05 | 35.89 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.31 | -0.21 | -0.24 | 0.02 | - | - |
Net Cash Flow | 4.58 | 1.6 | -47.67 | 41.52 | -24.5 | 26.93 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -57.44 | -45.71 | -34.63 | -25.32 | -25.63 | -8.96 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | -2618.65% | -1130.71% | -107.20% | -14.71% |
Free Cash Flow Per Share | -1.20 | -0.74 | -3.74 | -4.58 | -5.89 | -3.28 |
Levered Free Cash Flow | -28.84 | -21.99 | -22.1 | -17.95 | -14.29 | 3.28 |
Unlevered Free Cash Flow | -28.96 | -22.1 | -21.91 | -17.75 | -14.1 | 3.46 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.23 | 0.24 | 0.37 | 0.25 | 0.29 | - |
Cash Income Tax Paid | - | - | - | - | 0.03 | - |
Change in Working Capital | -4.51 | -3.69 | -2.3 | 2.33 | -0.24 | 11.68 |